Syngene InstaVisit

Targeted Protein Degradation

Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.

Literature / Brochures Released on 01.18.2021

Biologics and Manufacturing

Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.

Literature / Brochures Released on 01.15.2021

Your Pre-clinical Toxicology Program Needs a Strategy

At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.

Case Studies Released on 01.14.2021

Chemical Development

Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.

Literature / Brochures Released on 01.14.2021

The Dedicated Center

Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.

Case Studies Released on 01.13.2021

Clinical Development

Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.

Literature / Brochures Released on 01.13.2021

Proactive COVID-19 Testing

By identifying COVID-19 positive cases early on, particularly those that are asymptomatic, we can restrict further transmission of this deadly virus.

Case Studies Released on 01.12.2021

Commercial Manufacturing

Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.

Literature / Brochures Released on 01.12.2021

How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective

Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.

Case Studies Released on 01.11.2021

Formulation Development

Syngene supports both development and manufacturing of Drug Products from early to late stage.

Literature / Brochures Released on 01.11.2021

Harnessing Targeted Protein Degradation

Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.

Case Studies Released on 01.08.2021

ICH Stability Studies

One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.

Literature / Brochures Released on 01.08.2021